Annals of Oncology

in this issue

in this issue
Ann Oncol 2009 20: 1151; doi:10.1093/annonc/mdp339 [Extract] [Full Text] [PDF] [Request Permissions]  

editorial

N. Cherny

The use of sedation to relieve cancer patients' suffering at the end of life: addressing critical issues
Ann Oncol 2009 20: 1153-1155; doi:10.1093/annonc/mdp302 [Extract] [Full Text] [PDF] [Request Permissions]  

review

Get checked abstract C. H. Barrios, C. Sampaio, J. Vinholes, and R. Caponero

What is the role of chemotherapy in estrogen receptor-positive, advanced breast cancer?
Annals of Oncology Advance Access published on February 16, 2009
Ann Oncol 2009 20: 1157-1162; doi:10.1093/annonc/mdn756 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

original articles

quality of life/supportive care/palliative care

Get checked abstract M. Maltoni, C. Pittureri, E. Scarpi, L. Piccinini, F. Martini, P. Turci, L. Montanari, O. Nanni, and D. Amadori

Palliative sedation therapy does not hasten death: results from a prospective multicenter study
Ann Oncol 2009 20: 1163-1169; doi:10.1093/annonc/mdp048 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

Get checked abstract J. W. Han, S. Y. Kwon, S. C. Won, Y. J. Shin, J. H. Ko, and C. J. Lyu

Comprehensive clinical follow-up of late effects in childhood cancer survivors shows the need for early and well-timed intervention
Annals of Oncology Advance Access published on March 6, 2009
Ann Oncol 2009 20: 1170-1177; doi:10.1093/annonc/mdn778 [Abstract] [Full Text] [PDF] [Supplementary Data] [Request Permissions]  

breast cancer

Get checked abstract M. Colleoni, V. Bagnardi, N. Rotmensz, S. Dellapasqua, G. Viale, G. Pruneri, P. Veronesi, R. Torrisi, A. Luini, M. Intra, V. Galimberti, E. Montagna, and A. Goldhirsch

A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancer
Annals of Oncology Advance Access published on February 13, 2009
Ann Oncol 2009 20: 1178-1184; doi:10.1093/annonc/mdn747 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract G. Frasci, P. Comella, M. Rinaldo, G. Iodice, M. Di Bonito, M. D'Aiuto, A. Petrillo, S. Lastoria, C. Siani, G. Comella, and G. D'Aiuto

Preoperative weekly cisplatin–epirubicin–paclitaxel with G-CSF support in triple-negative large operable breast cancer
Annals of Oncology Advance Access published on February 13, 2009
Ann Oncol 2009 20: 1185-1192; doi:10.1093/annonc/mdn748 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract V. Guarneri, F. Piacentini, G. Ficarra, A. Frassoldati, R. D'Amico, S. Giovannelli, A. Maiorana, G. Jovic, and P. Conte

A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy
Annals of Oncology Advance Access published on February 16, 2009
Ann Oncol 2009 20: 1193-1198; doi:10.1093/annonc/mdn761 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract J.-L. Bulliard, C. Ducros, C. Jemelin, B. Arzel, G. Fioretta, and F. Levi

Effectiveness of organised versus opportunistic mammography screening
Annals of Oncology Advance Access published on March 12, 2009
Ann Oncol 2009 20: 1199-1202; doi:10.1093/annonc/mdn770 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract P. Hadji, M. Ziller, D. G. Kieback, W. Dornoff, H. W. Tessen, T. Menschik, J. Kuck, F. Melchert, and A. Hasenburg

Effects of exemestane and tamoxifen on bone health within the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial: results of a German, 12-month, prospective, randomised substudy
Annals of Oncology Advance Access published on February 13, 2009
Ann Oncol 2009 20: 1203-1209; doi:10.1093/annonc/mdn762 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract N. Katsumata, T. Watanabe, H. Minami, K. Aogi, T. Tabei, M. Sano, N. Masuda, J. Andoh, T. Ikeda, T. Shibata, and S. Takashima

Phase III trial of doxorubicin plus cyclophosphamide (AC), docetaxel, and alternating AC and docetaxel as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802)
Annals of Oncology Advance Access published on March 2, 2009
Ann Oncol 2009 20: 1210-1215; doi:10.1093/annonc/mdn781 [Abstract] [Full Text] [PDF] [Request Permissions]  

gastrointestinal tumors

Get checked abstract S. de Vogel, M. P. Weijenberg, J. G. Herman, K. A. D. Wouters, A. F. P. M. de Goeij, P. A. van den Brandt, A. P. de Bruïne, and M. van Engeland

MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events
Annals of Oncology Advance Access published on January 22, 2009
Ann Oncol 2009 20: 1216-1222; doi:10.1093/annonc/mdn782 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract S. J. Cohen, C. J. A. Punt, N. Iannotti, B. H. Saidman, K. D. Sabbath, N. Y. Gabrail, J. Picus, M. A. Morse, E. Mitchell, M. C. Miller, G. V. Doyle, H. Tissing, L. W. M. M. Terstappen, and N. J. Meropol

Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer
Annals of Oncology Advance Access published on March 12, 2009
Ann Oncol 2009 20: 1223-1229; doi:10.1093/annonc/mdn786 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract A. Buhmeida, R. Bendardaf, M. Hilska, J. Laine, Y. Collan, M. Laato, K. Syrjänen, and S. Pyrhönen

PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma
Annals of Oncology Advance Access published on March 10, 2009
Ann Oncol 2009 20: 1230-1235; doi:10.1093/annonc/mdn783 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract N. Kemeny, M. Capanu, M. D'Angelica, W. Jarnagin, D. Haviland, R. Dematteo, and Y. Fong

Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer
Annals of Oncology Advance Access published on February 20, 2009
Ann Oncol 2009 20: 1236-1241; doi:10.1093/annonc/mdn769 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract B. Burtness, M. Gibson, B. Egleston, R. Mehra, L. Thomas, R. Sipples, M. Quintanilla, J. Lacy, S. Watkins, J. R. Murren, and A. A. Forastiere

Phase II trial of docetaxel–irinotecan combination in advanced esophageal cancer
Annals of Oncology Advance Access published on May 8, 2009
Ann Oncol 2009 20: 1242-1248; doi:10.1093/annonc/mdn787 [Abstract] [Full Text] [PDF] [Request Permissions]  

lung cancer

Get checked abstract E. H. Tan, J. Rolski, T. Grodzki, C. P. Schneider, U. Gatzemeier, P. Zatloukal, E. Aitini, G. Carteni, H. Riska, Y. H. Tsai, and R. Abratt

Global Lung Oncology Branch trial 3 (GLOB3): final results of a randomised multinational phase III study alternating oral and i.v. vinorelbine plus cisplatin versus docetaxel plus cisplatin as first-line treatment of advanced non-small-cell lung cancer
Annals of Oncology Advance Access published on March 10, 2009
Ann Oncol 2009 20: 1249-1256; doi:10.1093/annonc/mdn774 [Abstract] [Full Text] [PDF] [Request Permissions]  

Get checked abstract D. Planchard, J. Domont, E. Taranchon, I. Monnet, J. Tredaniel, R. Caliandro, P. Validire, B. Besse, J.-C. Soria, and P. Fouret

The NER proteins are differentially expressed in ever smokers and in never smokers with lung adenocarcinoma
Annals of Oncology Advance Access published on March 17, 2009
Ann Oncol 2009 20: 1257-1263; doi:10.1093/annonc/mdn785 [Abstract] [Full Text] [PDF] [Request Permissions]  

urogenital tumors

Get checked abstract C. N. Sternberg, H. Dumez, H. Van Poppel, I. Skoneczna, A. Sella, G. Daugaard, T. Gil, J. Graham, P. Carpentier, F. Calabro, L. Collette, D. Lacombe, and for the EORTC Genitourinary Tract Cancer Group

Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer
Annals of Oncology Advance Access published on March 17, 2009
Ann Oncol 2009 20: 1264-1269; doi:10.1093/annonc/mdn784 [Abstract] [Full Text] [PDF] [Request Permissions]  

hematologic malignancies

Get checked abstract J. Markova, C. Kobe, M. Skopalova, K. Klaskova, K. Dedeckova, A. Plütschow, H. T. Eich, M. Dietlein, A. Engert, and T. Kozak

FDG–PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive value
Annals of Oncology Advance Access published on February 19, 2009
Ann Oncol 2009 20: 1270-1274; doi:10.1093/annonc/mdn768 [Abstract] [Full Text] [PDF] [Request Permissions]  

head and neck cancer

Get checked abstract C. M. Nutting, C. M. L. van Herpen, A. B. Miah, S. A. Bhide, J.-P. Machiels, J. Buter, C. Kelly, D. de Raucourt, and K. J. Harrington

Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma
Annals of Oncology Advance Access published on February 26, 2009
Ann Oncol 2009 20: 1275-1279; doi:10.1093/annonc/mdn775 [Abstract] [Full Text] [PDF] [Request Permissions]  

letters to the editor

M. Wong, S.-P. Choo, and E.-H. Tan

Travel warning with capecitabine
Annals of Oncology Advance Access published on May 26, 2009
Ann Oncol 2009 20: 1281; doi:10.1093/annonc/mdp278 [Extract] [FREE Full Text] [PDF] [Request Permissions]  

C. Rousset-Jablonski, J.-C. Thalabard, and A. Gompel

Tamoxifen contraindicated in women with hereditary angioedema?
Annals of Oncology Advance Access published on May 29, 2009
Ann Oncol 2009 20: 1281-1282; doi:10.1093/annonc/mdp295 [Extract] [Full Text] [PDF] [Request Permissions]  

M. Khasraw and S. Baron-Hay

Immune thrombocytopenic purpura (ITP) and breast cancer. Does adjuvant therapy for breast cancer improve platelet counts in ITP?
Ann Oncol 2009 20: 1282-1283; doi:10.1093/annonc/mdp305 [Extract] [Full Text] [PDF] [Request Permissions]  

I. G. Glezerman

Successful treatment of ifosfamide-induced hyponatremia with AVP receptor antagonist without interruption of hydration for prevention of hemorrhagic cystitis
Ann Oncol 2009 20: 1283-1285; doi:10.1093/annonc/mdp312 [Extract] [Full Text] [PDF] [Request Permissions]  

O. Díez and S. Gutiérrez-Enríquez

BRCA2 splice site mutations in an Italian breast/ovarian cancer family
Ann Oncol 2009 20: 1285; doi:10.1093/annonc/mdp316 [Extract] [Full Text] [PDF] [Request Permissions]  

M. Pensabene, I. Spagnoletti, I. Capuano, C. Condello, S. Pepe, A. Contegiacomo, G. Lombardi, G. Bevilacqua, and M. A. Caligo

Reply to BRCA2 splice site mutations in an Italian breast/ovarian cancer family
Ann Oncol 2009 20: 1285-1286; doi:10.1093/annonc/mdp321 [Extract] [Full Text] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.